Amanhã, maiores avanços no diagnóstico, tratamento e prevenção da doença de Alzheimer e outras demências.
Gratuito, com coffee, almoço e certificados :)
Vejo vocês lá!
simpcentrodamemoria.eventize…
You never forget your first time 💚
The @borelli_lab team is heading for the first time to #AAIC2025, the world’s biggest event on Alzheimer’s and dementia research!
We’ve won travel awards to share our science from 🇧🇷
🗓 July 27–31 | 📍Toronto 🇨🇦
Check out our presentations!
Dr. @vbwyll in action at @congressobrain, presenting on blood biomarkers for Alzheimer’s disease 🧠🩸 — discussing when and how to implement them in clinical practice. An important step toward more accessible and earlier diagnosis.
👋 Hello, nice to meet you — we’re just getting started!
We are a research group led by Dr. @vbwyll, dedicated to studying Alzheimer’s and related dementias 🧠
Our mission: advance prevention, early diagnosis, and treatment through neuroscience!
There’s no doubt that anti-amyloid will increase health discrepancy - the discussion is about the next steps.
Great discussion on Leqembi, UK, Japan and the recent European decision:
alzforum.org/news/conference…
Wanna hear about blood-based biomarkers in LMIC and their clinical implementation?
Check our webinar hosted by @ISTAART PIA Real World Translation Work Group.
👇
Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)
Last week, the XXXI Brazilian Congress of Neurology took place, the largest event in this field in 🇧🇷! Organized by ABN, it gathered over 5k participants and featured 380 presentations in Campinas.
Check out highlights from Dr. @erzimmer and Dr. @vbwyll!
Precision brain health can evolve by integrating computational frameworks of brain clocks multimodal diversity, showing how inequities and exposomes impact brain health. Out in @NatureMedicine, written with editors & the great @SandraBez9@vbwyll 👉doi.org/10.1038/s41591-024-0…
Part of the task force that published the guidelines for the use of AD biomarkers and potential use of anti-amyloid therapies in Brazil. It was an honor to work with the greatest references in this field in Brazil
Today, @abneuro_ published guidelines for using #AlzheimersDisease biomarkers and anti-amyloid therapies in Brazil, a country with significant challenges. I am glad to have led this task force with colleagues and mentors. Articles available at @DementiaNeuro (links below)
Palestra incrível do @leandrominozzo sobre a política nacional de cuidado integral a pessoas com doença de Alzheimer e outras demências. Muita coisa boa para celebrar! @erzimmer e #nitrini em foco
We are pleased to welcome these distinguished researchers and clinicians into the ISTAART Advisory Council (IAC)!
Excited to work with them and the rest of the Council to set ISTAART's direction over the next 2 years.
See the full IAC at istaart.alz.org/about#IAC
During my first ISTAART advisory council meeting, it was clear that everyone was sad that @CaramelliPaulo was leaving, though happy that @claire_e_sexton , @ozy_ismail @alladi_suvarna and #Zetterberg were leading the council. I am incredibly thankful for this opportunity
It has been a privilege to serve on the @ISTAART advisory council. I have learned so much from experts in the field (some pictured here at #AAIC24) & look forward to paying this forward. Thank you @alzassociation@claire_e_sexton & @ozy_ismail for this incredible opportunity! 💜